A detailed history of Oberweis Asset Management Inc transactions in Liquidia Corp stock. As of the latest transaction made, Oberweis Asset Management Inc holds 250,900 shares of LQDA stock, worth $2.89 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
250,900
Previous 183,200 36.95%
Holding current value
$2.89 Million
Previous $2.2 Million 14.15%
% of portfolio
0.14%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$8.9 - $14.11 $602,530 - $955,247
67,700 Added 36.95%
250,900 $2.51 Million
Q2 2024

Aug 14, 2024

BUY
$11.96 - $15.71 $397,072 - $521,572
33,200 Added 22.13%
183,200 $2.2 Million
Q1 2024

May 15, 2024

BUY
$11.35 - $16.73 $1.7 Million - $2.51 Million
150,000 New
150,000 $2.21 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $742M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.